At the same time, a substantial proportion of uptake reflected switching from injectable AOM GLP-1-based medications, particularly AOM tirzepatide and injectable AOM semaglutide
Current evidence regarding the impact of GLP-1 receptor agonists on ophthalmic diseases remains inconsistent. Retinopathy remains the dominant concern Much of the ophthalmic attention surrounding GLP-1 therapies traces back to DR
In these cases, provider evaluation must address whether baseline thyroid function is stable, TSH is well-controlled, and whether introducing a GLP-1 agent poses any incremental autoimmune risk for that individual
Higher GH levels induced by Ipamorelin contribute to deep sleep, and its stimulation of natural GH production may delay the aging process
Provider-led plans & ongoing support Licensed providers in your state, available for check-ins
Side Effects and Management Strategies Side effects with Retatrutide follow predictable patterns that allow proactive management